Related Experiment Video
Updated: Aug 17, 2025

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains
Daria S Yampolskaya1, Galina V Kopylova2, Daniil V Shchepkin2
1Bach Institute of Biochemistry, Biotechnology Research Center, Russian Academy of Sciences, Moscow, 119071, Russia.
Insights
Cardiomyopathy mutations in the MYL3 gene affect cardiac myosin function differently. While some mutations alter actin-myosin interactions, impacting muscle contraction, their precise mechanisms vary.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Hypertrophic cardiomyopathy is linked to mutations in cardiac myosin genes.
- The essential light chain of ventricular myosin (ELCv) plays a crucial role in cardiac muscle function.
- Understanding the impact of specific mutations on myosin function is key to elucidating disease mechanisms.
Purpose of the Study:
- To investigate the functional consequences of cardiomyopathic mutations (E56G, M149V, E177G) in the MYL3 gene on human ventricular myosin (ELCv).
- To determine how these mutations affect the actin-myosin interaction at the level of myosin subfragment 1 (S1) and in an in vitro motility assay.
Main Methods:
- Investigated the actin-activated ATPase activity of isolated myosin subfragment 1 (S1).
- Utilized an in vitro motility assay to assess the Ca2+-sensitivity and sliding velocity of thin filaments on immobilized myosin.
- Examined the effects on regulated thin filaments and F-actin filaments.
Main Results:
- The M149V mutation uniquely increased the actin-activated ATPase activity of S1.
- All studied mutations significantly enhanced the Ca2+-sensitivity of sliding velocity.
- Mutations E56G and M149V markedly reduced sliding velocity, while E177G did not.
Conclusions:
- Despite all mutations being associated with hypertrophic cardiomyopathy, they exert distinct effects on actin-myosin interactions.
- The findings highlight diverse molecular mechanisms underlying ELCv-related cardiomyopathies.
- This study provides insights into the structure-function relationships of cardiac myosin.
Abstract:
The effects of cardiomyopathic mutations E56G, M149V, and E177G in the MYL3 gene encoding essential light chain of human ventricular myosin (ELCv), on the functional properties of cardiac myosin and its isolated head (myosin subfragment 1, S1) were investigated. Only the M149V mutation upregulated the actin-activated ATPase activity of S1. All mutations significantly increased the Ca2+-sensitivity of the sliding velocity of thin filaments on the surface with immobilized myosin in the in vitro motility assay, while mutations E56G and M149V (but not E177G) reduced the sliding velocity of regulated thin filaments and F-actin filaments almost twice. Therefore, despite the fact that all studied mutations in ELCv are involved in the development of hypertrophic cardiomyopathy, the mechanisms of their influence on the actin-myosin interaction are different.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Overview of Myosin Structure and Function
Cardiomyopathy I: Introduction and Classification
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy II: Dilated Cardiomyopathy

